Sort   by:  
 Page size 
UnknownUp to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.
Not available
S-EPMC7371673 | biostudies-literature
UnknownIdentification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study.
Not available
S-EPMC9009012 | biostudies-literature
UnknownPhase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
Not available
S-EPMC11015975 | biostudies-literature
UnknownTailoring a Global Iron Regulon to a Uropathogen.
Not available
S-EPMC7157518 | biostudies-literature
UnknownTransplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial.
Not available
S-EPMC11926625 | biostudies-literature
UnknownSaliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults.
Not available
S-EPMC10382861 | biostudies-literature
UnknownNivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Not available
S-EPMC10646780 | biostudies-literature
UnknownMajor Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
Not available
S-EPMC5877802 | biostudies-literature
UnknownRandomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
Not available
S-EPMC4878106 | biostudies-literature
UnknownEnasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
Not available
S-EPMC10644040 | biostudies-literature
Sort   by:  
 Page size